Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, November 30, 2023
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
Wed, November 29, 2023
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
Mitchell Kapoor Reiterated (carm) at Strong Buy and Held Target at $11 on, Nov 29th, 2023
Mitchell Kapoor of HC Wainwright & Co., Reiterated "Carisma Therapeutics, Inc." (CARM) at Strong Buy and Held Target at $11 on, Nov 29th, 2023.
Mitchell has made no other calls on CARM in the last 4 months.
There is 1 other peer that has a rating on CARM. Out of the 1 peers that are also analyzing CARM, 0 agree with Mitchell's Rating of Hold.
This is the rating of the analyst that currently disagrees with Mitchell
- Naureen Quibria of "Capital One" Initiated at Buy and Held Target at $10 on, Tuesday, October 3rd, 2023
